Mechanistically, RASSF4 suppresses tumor growth by modulating critical signaling pathways, including the Hippo, RAS/MAPK, and PI3K/AKT cascades, thereby influencing tumor cell fate [2,27,36]. The gene discussed is AKT1; the disease is neoplasm.